Carrier rate of Canavan disease among Ashkenazi Jewish individuals
Journal Article
·
· American Journal of Human Genetics
OSTI ID:133916
- Miami Children`s Hospital, Miami, FL (United States)
Canavan Disease (CD) is a severe leukodystrophy prevalent among people of Ashkenazi Jewish extraction. The incidence of CD is unknown although it has been stated to be rare. The human aspartoacylase gene has been cloned and mutation determined in 50 Jewish patients with CD. Four mutations were identified in 99 of 100 alleles. A missense mutation, E285A, accounted for 83% of the alleles; a second mutation, Y231X, was found in 13% of the alleles; two other mutations accounted for 3 alleles. In non-Jewish individuals with CD, 52 alleles were examined and 11 mutations were observed. In order to determine the rate of carriers in the Ashkenazi Jewish population, 2,700 blood specimens from unrelated healthy individuals were studied using a panel of 4 mutations found in Jewish individuals. Genomic DNA was amplified by PCR and analyzed for single strand conformation polymorphism. The mutations identified were confirmed by restriction digestion. Sixty carriers were identified, suggesting a carrier rate of 1:45. Of the 60 carriers, 52 had E285A mutation and 8 had Y231X. The proportion of E285A and Y231X mutations in the Jewish population was 86.7% and 13.3%, respectively, in agreement with the relative distribution seen in patients with CD. These studies are being expanded to a larger sample so that other mutations are identified. Our data suggest higher than expected carrier rate for CD in Ashkenazi Jews. It seems that carrier testing for preventive counseling should be applied in the risk population.
- OSTI ID:
- 133916
- Report Number(s):
- CONF-941009--
- Journal Information:
- American Journal of Human Genetics, Journal Name: American Journal of Human Genetics Journal Issue: Suppl.3 Vol. 55; ISSN AJHGAG; ISSN 0002-9297
- Country of Publication:
- United States
- Language:
- English
Similar Records
Spectrum of Canavan mutations among Jewish and non-Jewish patients
Prevalance of Canavan disease heterozygotes in the New York Metropolitan Ashkenazi Jewish population
The molecular basis of Canavan (Aspartoacylase deficiency) disease in European non-Jewish patients
Journal Article
·
Thu Sep 01 00:00:00 EDT 1994
· American Journal of Human Genetics
·
OSTI ID:133427
Prevalance of Canavan disease heterozygotes in the New York Metropolitan Ashkenazi Jewish population
Journal Article
·
Tue Oct 31 23:00:00 EST 1995
· American Journal of Human Genetics
·
OSTI ID:209921
The molecular basis of Canavan (Aspartoacylase deficiency) disease in European non-Jewish patients
Journal Article
·
Fri Sep 01 00:00:00 EDT 1995
· American Journal of Human Genetics
·
OSTI ID:110952